Establishment Labs (ESTA) Competitors $43.89 -0.47 (-1.06%) As of 07/3/2025 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. NARI, TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, WRBY, and NVCRShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Its Competitors Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker NovoCure Establishment Labs (NASDAQ:ESTA) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation. Do insiders and institutionals believe in ESTA or NARI? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 11.1% of Establishment Labs shares are held by company insiders. Comparatively, 10.6% of Inari Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor ESTA or NARI? In the previous week, Establishment Labs had 3 more articles in the media than Inari Medical. MarketBeat recorded 3 mentions for Establishment Labs and 0 mentions for Inari Medical. Establishment Labs' average media sentiment score of 0.42 beat Inari Medical's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the media. Company Overall Sentiment Establishment Labs Neutral Inari Medical Neutral Which has more volatility and risk, ESTA or NARI? Establishment Labs has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Is ESTA or NARI more profitable? Inari Medical has a net margin of -13.68% compared to Establishment Labs' net margin of -52.34%. Inari Medical's return on equity of -10.09% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-52.34% -196.25% -26.64% Inari Medical -13.68%-10.09%-6.60% Which has preferable valuation & earnings, ESTA or NARI? Inari Medical has higher revenue and earnings than Establishment Labs. Inari Medical is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$166.02M7.65-$84.60M-$3.10-14.16Inari Medical$493.63M9.48-$1.64M-$1.35-59.24 Do analysts prefer ESTA or NARI? Establishment Labs presently has a consensus target price of $52.40, indicating a potential upside of 19.39%. Inari Medical has a consensus target price of $69.22, indicating a potential downside of 13.44%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts clearly believe Establishment Labs is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 SummaryInari Medical beats Establishment Labs on 9 of the 16 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.26B$7.31B$5.56B$9.04BDividend YieldN/A2.78%5.24%4.01%P/E Ratio-14.1627.9427.6420.24Price / Sales7.6532.38416.55117.31Price / CashN/A22.0136.8958.10Price / Book23.106.698.035.67Net Income-$84.60M$233.06M$3.18B$249.21M7 Day Performance7.23%3.33%2.93%3.28%1 Month Performance15.50%1.79%1.72%3.95%1 Year Performance1.53%37.40%34.39%20.98% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs1.2347 of 5 stars$43.89-1.1%$52.40+19.4%+1.5%$1.26B$166.02M-14.161,018NARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.5998 of 5 stars$134.01+1.9%$127.33-5.0%-15.5%$4.45B$441.54M98.54210Positive NewsBLCOBausch + Lomb3.1082 of 5 stars$13.03+5.1%$15.54+19.3%-6.0%$4.39B$4.79B-12.6513,500High Trading VolumeSLNOSoleno Therapeutics4.3716 of 5 stars$83.78+0.6%$107.10+27.8%+111.8%$4.20BN/A-18.1330Insider TradeINSPInspire Medical Systems4.8489 of 5 stars$129.28-2.4%$211.91+63.9%-9.0%$3.91B$802.80M59.581,246NVSTEnvista3.7745 of 5 stars$19.58-0.5%$20.23+3.3%+24.3%$3.33B$2.51B-3.0012,300News CoveragePRCTPROCEPT BioRobotics2.4088 of 5 stars$57.60+1.2%$90.00+56.3%-8.8%$3.15B$224.50M-33.88430Positive NewsLIVNLivaNova3.2273 of 5 stars$45.02-1.6%$59.29+31.7%-12.1%$2.49B$1.25B-11.012,900News CoveragePositive NewsWRBYWarby Parker2.2199 of 5 stars$21.94+0.2%$22.88+4.3%+41.5%$2.29B$771.32M-182.833,780Positive NewsNVCRNovoCure3.6021 of 5 stars$17.80-1.1%$32.83+84.5%+5.5%$2.01B$605.22M-11.791,488 Related Companies and Tools Related Companies Inari Medical Alternatives TransMedics Group Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives Inspire Medical Systems Alternatives Envista Alternatives PROCEPT BioRobotics Alternatives LivaNova Alternatives Warby Parker Alternatives NovoCure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
